- CA$9.53m
- CA$18.74m
- CA$11.17m
- 45
- 55
- 38
- 43
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.07 | 6.11 | 11.4 | 10.5 | 11.2 |
Cost of Revenue | |||||
Gross Profit | 0.899 | 1.97 | 5.5 | 5.07 | 6.03 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.72 | 13.4 | 18.4 | 17.7 | 18 |
Operating Profit | -5.65 | -7.33 | -7.02 | -7.23 | -6.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.39 | -10.1 | -7.73 | -7.65 | -7.7 |
Net Income After Taxes | -6.39 | -10.1 | -7.73 | -7.65 | -7.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.39 | -10.1 | -7.73 | -7.65 | -7.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.39 | -10.1 | -7.73 | -7.65 | -7.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.07 | -0.116 | -0.113 | -0.076 | -0.065 |
Dividends per Share |